Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jack Henningfield

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Psychopharmacology|November 27, 2004
Calorie restriction increases cigarette use in adult smokersLawrence J Cheskin, Judith M Hess, Jack Henningfield, et al.
Drug Testing and Analysis|May 18, 2026
Assessment of Abuse Potential-Related Effects of Oral Dried Kratom Leaf Powder in Healthy Normal Participants Following Single and Multiple Daily DosesMarion Coe, Marilyn Huestis, Daniel Wang, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|October 27, 2012
Nicotine reduction: strategic research planDorothy K Hatsukami, Neal L Benowitz, Eric Donny, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|June 19, 2004
Nicotine dependence criteria of the DIS and DSM-III-R: a factor analysisAleksandras Radzius, Joseph Gallo, David Gorelick, et al.
Journal of Clinical Psychopharmacology|June 24, 2022
Abuse Potential of Lemborexant, a Dual Orexin Receptor Antagonist, Compared With Zolpidem and Suvorexant in Recreational Sedative UsersIshani Landry, Nancy Hall, Jagadeesh Aluri, et al.
Journal of Clinical Psychopharmacology|June 24, 2022
Acute Cognitive Effects of the Dual Orexin Receptor Antagonist Lemborexant Compared With Suvorexant and Zolpidem in Recreational Sedative UsersIshani Landry, Nancy Hall, Jagadeesh Alur, et al.
Journal of Dual Diagnosis|December 28, 2023
Prevalence, Characteristics, and Reasons for Kratom Use among Psychiatrically Ill Inpatients Who Use SubstancesCornel N Stanciu, Saeed Ahmed, Zouina Sarfraz, et al.
Pain Medicine (Malden, Mass.)|March 25, 2017
Human Abuse Potential of the New Opioid Analgesic Molecule NKTR-181 Compared with OxycodoneLynn Webster, Jack Henningfield, August R Buchhalter, et al.
Scientific Reports|July 6, 2022
REL-1017 (esmethadone; D-methadone) does not cause reinforcing effect, physical dependence and withdrawal signs in Sprague Dawley ratsJack Henningfield, David Gauvin, Francesco Bifari, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Psychopharmacology|November 27, 2004
Calorie restriction increases cigarette use in adult smokersLawrence J Cheskin, Judith M Hess, Jack Henningfield, et al.
Drug Testing and Analysis|May 18, 2026
Assessment of Abuse Potential-Related Effects of Oral Dried Kratom Leaf Powder in Healthy Normal Participants Following Single and Multiple Daily DosesMarion Coe, Marilyn Huestis, Daniel Wang, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|October 27, 2012
Nicotine reduction: strategic research planDorothy K Hatsukami, Neal L Benowitz, Eric Donny, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|June 19, 2004
Nicotine dependence criteria of the DIS and DSM-III-R: a factor analysisAleksandras Radzius, Joseph Gallo, David Gorelick, et al.
Journal of Clinical Psychopharmacology|June 24, 2022
Abuse Potential of Lemborexant, a Dual Orexin Receptor Antagonist, Compared With Zolpidem and Suvorexant in Recreational Sedative UsersIshani Landry, Nancy Hall, Jagadeesh Aluri, et al.
Journal of Clinical Psychopharmacology|June 24, 2022
Acute Cognitive Effects of the Dual Orexin Receptor Antagonist Lemborexant Compared With Suvorexant and Zolpidem in Recreational Sedative UsersIshani Landry, Nancy Hall, Jagadeesh Alur, et al.
Journal of Dual Diagnosis|December 28, 2023
Prevalence, Characteristics, and Reasons for Kratom Use among Psychiatrically Ill Inpatients Who Use SubstancesCornel N Stanciu, Saeed Ahmed, Zouina Sarfraz, et al.
Pain Medicine (Malden, Mass.)|March 25, 2017
Human Abuse Potential of the New Opioid Analgesic Molecule NKTR-181 Compared with OxycodoneLynn Webster, Jack Henningfield, August R Buchhalter, et al.
Scientific Reports|July 6, 2022
REL-1017 (esmethadone; D-methadone) does not cause reinforcing effect, physical dependence and withdrawal signs in Sprague Dawley ratsJack Henningfield, David Gauvin, Francesco Bifari, et al.
Pageof 1